1. Lu, Chenglu, Chen, Shuai, Liu, Shasha, Sun, Lin, Sun, Yan. 2024. Determination of the Immunomodulatory Role of OTOP2 in Colon Adenocarcinoma. In Journal of Cancer, 15, 4838-4852. doi:10.7150/jca.95622. https://pubmed.ncbi.nlm.nih.gov/39132149/
2. Guo, Shuai, Sun, Yang. 2022. OTOP2, Inversely Modulated by miR-3148, Inhibits CRC Cell Migration, Proliferation and Epithelial-Mesenchymal Transition: Evidence from Bioinformatics Data Mining and Experimental Verification. In Cancer management and research, 14, 1371-1384. doi:10.2147/CMAR.S345299. https://pubmed.ncbi.nlm.nih.gov/35418782/
3. Qu, Huajun, Su, Yi, Yu, Lianzhi, Zhao, Hongchao, Xin, Chunxia. 2018. Wild-type p53 regulates OTOP2 transcription through DNA loop alteration of the promoter in colorectal cancer. In FEBS open bio, 9, 26-34. doi:10.1002/2211-5463.12554. https://pubmed.ncbi.nlm.nih.gov/30652071/
4. Tu, Yu-Hsiang, Cooper, Alexander J, Teng, Bochuan, Smith, Andrew D, Liman, Emily R. 2018. An evolutionarily conserved gene family encodes proton-selective ion channels. In Science (New York, N.Y.), 359, 1047-1050. doi:10.1126/science.aao3264. https://pubmed.ncbi.nlm.nih.gov/29371428/
5. Sallinger, Katja, Gruber, Michael, Müller, Christin-Therese, Kroneis, Thomas, El-Heliebi, Amin. 2023. Spatial tumour gene signature discriminates neoplastic from non-neoplastic compartments in colon cancer: unravelling predictive biomarkers for relapse. In Journal of translational medicine, 21, 528. doi:10.1186/s12967-023-04384-0. https://pubmed.ncbi.nlm.nih.gov/37543577/
6. Sumalde, Angelo Augusto M, Scholes, Melissa A, Kalmanson, Olivia A, Hadley-Miller, Nancy, Santos-Cortez, Regie Lyn P. 2023. Rare Coding Variants in Patients with Non-Syndromic Vestibular Dysfunction. In Genes, 14, . doi:10.3390/genes14040831. https://pubmed.ncbi.nlm.nih.gov/37107589/
智鼠故事 
